Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2009151598) DIAZACARBAZOLES AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2009/151598 International Application No.: PCT/US2009/003492
Publication Date: 17.12.2009 International Filing Date: 10.06.2009
Chapter 2 Demand Filed: 12.04.2010
IPC:
C07D 471/14 (2006.01) ,A61K 31/437 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
12
in which the condensed system contains three hetero rings
14
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
DYKE, Hazel, Joan [GB/GB]; GB (UsOnly)
ELLWOOD, Charles [GB/GB]; GB (UsOnly)
GANCIA, Emanuela [IT/GB]; GB (UsOnly)
GAZZARD, Lewis, J. [GB/US]; US (UsOnly)
GOODACRE, Simon, Charles [GB/GB]; GB (UsOnly)
KINTZ, Samuel, S. [US/US]; US (UsOnly)
LYSSIKATOS, Joseph, P. [US/US]; US (UsOnly)
MACLEOD, Calum [GB/GB]; GB (UsOnly)
WILLIAMS, Karen [GB/GB]; GB (UsOnly)
CHEN, Huifen [US/US]; US (UsOnly)
GENENTECH, INC. [US/US]; 1 DNA Way South San Francisco, CA 94080, US (AllExceptUS)
Inventors:
DYKE, Hazel, Joan; GB
ELLWOOD, Charles; GB
GANCIA, Emanuela; GB
GAZZARD, Lewis, J.; US
GOODACRE, Simon, Charles; GB
KINTZ, Samuel, S.; US
LYSSIKATOS, Joseph, P.; US
MACLEOD, Calum; GB
WILLIAMS, Karen; GB
CHEN, Huifen; US
Agent:
BUCKWALTER, Brian, L.; Genentech, Inc. 1 DNA Way, MS-49 South San Francisco, CA 94080, US
Priority Data:
61/060,74611.06.2008US
61/148,00128.01.2009US
Title (EN) DIAZACARBAZOLES AND METHODS OF USE
(FR) DIAZACARBAZOLES ET PROCÉDÉS D'UTILISATION
Abstract:
(EN) The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chkl) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
(FR) La présente invention concerne des composés 1,7-diazacarbazole de formule (I), (I-a) et (I-b) qui sont utiles comme inhibiteurs des kinases, plus spécifiquement utiles comme inhibiteurs des checkpoint kinases 1 (chkl), donc utiles comme agents thérapeutiques anticancéreux. L'invention concerne également des compositions, plus spécifiquement des compositions pharmaceutiques comprenant ces composés et des procédés permettant de les utiliser pour traiter diverses formes de cancer et de troubles hyperprolifératifs, ainsi que des procédés d'utilisation des composés pour le diagnostic ou le traitement in vitro, in situ, et in vivo de cellules de mammifères, ou d'affections pathologiques associées.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)